02/07/2019 12:48 Relevant Fact: Significant Participations
Significant shareholdings. June 30, 2019
| Shareholders |
% direct shareholding |
% indirect shareholding (*) |
% total shareholding |
| KANEKA EUROPE HOLDING COMPANY NV |
39,76% |
|
39,76% |
| D. Miquel Àngel Bonachera Sierra |
8,92% |
|
8,92% |
| D. Sergi Audivert Brugué |
8,92% |
|
8,92% |
| D. Luis Sánchez Lafuente-Mario |
8,87% |
1,28% |
10,15% |
Shareholders that held 10% of the share capital of ABBIOTICS S.A, as well as those administrators or executives with more than 1% of the share capital.
(*) Luis Sánchez-Lafuente Mariol indirectly has an additional 1.28% through the Bio Littletec Society, S.L.
09/01/2019 18:27 Relevant Fact: Significant Participations
Significant shareholdings. December 31, 2018
| Shareholders |
% direct shareholding |
% indirect shareholding (*) |
% total shareholding |
| KANEKA EUROPE HOLDING COMPANY NV |
37,77% |
|
37,77% |
| D. Miquel Àngel Bonachera Sierra |
9,91% |
|
9,91% |
| D. Sergi Audivert Brugué |
9,91% |
|
9,91% |
| D. Luis Sánchez Lafuente-Mario |
8,87% |
1,28% |
10,15% |
Shareholders that held 10% of the share capital of ABBIOTICS S.A, as well as those administrators or executives with more than 1% of the share capital.
(*) Luis Sánchez-Lafuente Mariol indirectly has an additional 1.28% through the Bio Littletec Society, S.L.
04/07/2018 23:38 Relevant Fact: Significant Participations
Significant shareholdings. June 30, 2018
| Shareholders |
% direct shareholding |
% indirect shareholding |
% total shareholding |
| KANEKA EUROPE HOLDING COMPANY NV |
37,77% |
|
37,77% |
| D. Miquel Àngel Bonachera Sierra |
9,91% |
|
9,91% |
| D. Sergi Audivert Brugué |
9,91% |
|
9,91% |
| D. Luis Sánchez Lafuente-Mario |
8,87% |
0,92% |
9,79% |
| Biolittletec, S.L. |
1,15% |
|
1,15% |
Shareholders that held 10% of the share capital of ABBIOTICS S.A, as well as those administrators or executives with more than 1% of the share capital
09/04/2018 20:53 Relevant Fact: Significant Participations
Kaneka Europe Holding Company NV increases its participation in AB-Biotics
| Shareholders |
% direct shareholding |
% indirect shareholding |
% total shareholding |
| Kaneka Europe Holding Company NV |
|
|
34,05% |
| Miquel Àngel Bonachera Sierra |
|
|
10,11% |
| Sergi Audivert Brugué |
9,91% |
|
10,11% |
| Luis Sánchez Lafuente |
8,87% |
0,92% |
10,10% |
Shareholders that held 10% of the share capital of ABBIOTICS S.A, as well as those administrators or executives with more than 1% of the share capital
10/01/2018 15:21 Relevant Fact: Significant Participations
Significant shareholdings. December 31, 2017
| Shareholders |
% direct shareholding (*) |
| D. Miquel Àngel Bonachera Sierra |
10,11% |
| D. Sergi Audivert Brugué |
10,11% |
| D. Luis Sánchez-Lafuente Mariol |
7,63% |
| Seed Capital Fund, S.L. |
5,26% |
| Institut Català de Finances Capital SGECR, S.A.U |
3,29% |
| INFEMA, S.A. |
1,50% |
| Gestión y Administración Mobiliaria, S.A. |
5,16% |
| Corporación Ivamosa, S.A. |
5,16% |
Shareholders that held 10% of the share capital of ABBIOTICS S.A, as well as those administrators or executives with more than 1% of the share capital.
(*) Luis Sánchez-Lafuente Mariol indirectly has an additional 0.92% through the Bio Littletec Society, S.L.
05/07/2017 13:55 Relevant Fact: Significant Participations
Significant shareholdings. June 30, 2017.
| Shareholders |
% direct shareholding (*) |
| D. Miquel Àngel Bonachera Sierra |
10,11% |
| D. Sergi Audivert Brugué |
10,11% |
| D. Luis Sánchez-Lafuente Mariol |
7,63% |
| Seed Capital Fund, S.L. |
5,26% |
| Institut Català de Finances Capital SGECR, S.A.U |
3,29% |
| INFEMA, S.A. |
1,50% |
| Gestión y Administración Mobiliaria, S.A. |
5,16% |
| Corporación Ivamosa, S.A. |
5,16% |
Shareholders that held 10% of the share capital of ABBIOTICS S.A, as well as those administrators or executives with more than 1% of the share capital.
(*) Luis Sánchez-Lafuente Mariol indirectly has an additional 0.92% through the Bio Littletec Society, S.L.
10/01/2017 16:10 Relevant Fact: Significant Participations
Significant shareholdings. December 31, 2016.
| Shareholders |
% direct shareholding |
| D. Miquel Àngel Bonachera Sierra |
10,11% |
| D. Sergi Audivert Brugué |
10,11% |
| D. Luis Sánchez-Lafuente Mariol |
7,63% |
| Seed Capital Fund, S.L. |
5,26% |
| Institut Català de Finances Capital SGECR, S.A.U |
3,29% |
| INFEMA, S.A. |
1,50% |
Shareholders that held 10% of the share capital of ABBIOTICS S.A, as well as those administrators or executives with more than 1% of the share capital
03/10/2016 17:32 Relevant Fact: Significant Participations
Significant shareholdings update.
| Shareholders |
% direct shareholding (*) |
| D. Miquel Àngel Bonachera Sierra |
10,11% |
| D. Sergi Audivert Brugué |
10,11% |
| D. Luis Sánchez-Lafuente Mariol |
7,63% |
| Seed Capital Fund, S.L. |
5,26% |
| Institut Català de Finances Capital SGECR, S.A.U |
3,29% |
| INFEMA, S.A. |
1,50% |
Shareholders that held 10% of the share capital of ABBIOTICS S.A, as well as those administrators or executives with more than 1% of the share capital.
(*) Luis Sánchez-Lafuente Mariol indirectly has an additional 0.92% through the Bio Littletec Society, S.L.
06/07/2016 17:32 Relevant Fact: Significant Participations
Significant shareholdings. June 30, 2016.
| Shareholders |
% direct shareholding (*) |
| D. Miquel Àngel Bonachera Sierra |
13,07% |
| D. Sergi Audivert Brugué |
13,07% |
| D. Luis Sánchez-Lafuente Mariol |
9,29% |
| Seed Capital Fund, S.L. |
5,21% |
| Institut Català de Finances Capital SGECR, S.A.U |
3,88% |
| INFEMA, S.A. |
1,97% |
Shareholders that held 10% of the share capital of ABBIOTICS S.A, as well as those administrators or executives with more than 1% of the share capital.
(*) Luis Sánchez-Lafuente Mariol indirectly has an additional 1.51% through the Bio Littletec Society, S.L.
04/01/2016 17:32 Relevant Fact: Significant Participations
Significant shareholdings.
| Shareholders |
% direct shareholding (*) |
| D. Miquel Àngel Bonachera Sierra |
13,07% |
| D. Sergi Audivert Brugué |
13,07% |
| D. Luis Sánchez-Lafuente Mariol |
9,29% |
Shareholders that held 10% of the share capital of ABBIOTICS S.A, as well as those administrators or executives with more than 1% of the share capital.
(*) Luis Sánchez-Lafuente Mariol indirectly has an additional 1.21% through the Bio Littletec Society, S.L.
03/07/2015 09:40 Relevant Fact: Significant Participations
Significant shareholdings. June 30, 2015.
| Shareholders |
% direct shareholding (*) |
| D. Miquel Àngel Bonachera Sierra |
13,07% |
| D. Sergi Audivert Brugué |
13,07% |
| D. Luis Sánchez-Lafuente Mariol |
9,29% |
Shareholders that held 10% of the share capital of ABBIOTICS S.A, as well as those administrators or executives with more than 1% of the share capital.
(*) Luis Sánchez-Lafuente Mariol indirectly has an additional 1.21% through the Bio Littletec Society, S.L.
08/01/2015 15:20 Relevant Fact: Significant Participations
Significant shareholdings.
| Shareholders |
% direct shareholding (*) |
| D. Miquel Àngel Bonachera Sierra |
13,24% |
| D. Sergi Audivert Brugué |
13,24% |
| D. Luis Sánchez-Lafuente Mariol |
9,30% |
Shareholders that held 10% of the share capital of ABBIOTICS S.A, as well as those administrators or executives with more than 1% of the share capital.
(*) Luis Sánchez-Lafuente Mariol indirectly has an additional 1.21% through the Bio Littletec Society, S.L.
09/07/2014 14:15 Relevant Fact: Significant Participations
Significant shareholdings.
| Shareholders |
% direct shareholding (*) |
| D. Miquel Àngel Bonachera Sierra |
13,24% |
| D. Sergi Audivert Brugué |
13,24% |
| D. Luis Sánchez-Lafuente Mariol |
9,30% |
Shareholders that held 10% of the share capital of ABBIOTICS S.A, as well as those administrators or executives with more than 1% of the share capital.
(*) Luis Sánchez-Lafuente Mariol indirectly has an additional 1.21% through the Bio Littletec Society, S.L.
08/01/2014 20:15 Relevant Fact: Significant Participations
Significant shareholdings.
| Shareholders |
% direct shareholding (*) |
| D. Miquel Àngel Bonachera Sierra |
13,26% |
| D. Sergi Audivert Brugué |
13,26% |
| D. Luis Sánchez-Lafuente Mariol |
9,30% |
Shareholders that held 10% of the share capital of ABBIOTICS S.A, as well as those administrators or executives with more than 1% of the share capital.
(*) Luis Sánchez-Lafuente Mariol indirectly has an additional 1.21% through the Bio Littletec Society, S.L.
16/10/2013 18:47 Relevant Fact: Significant Participations
Significant shareholdings.
| Shareholders |
% direct shareholding (*) |
| D. Miquel Àngel Bonachera Sierra |
13,26% |
| D. Sergi Audivert Brugué |
13,26% |
| D. Luis Sánchez-Lafuente Mariol |
9,30% |
Shareholders that held 10% of the share capital of ABBIOTICS S.A, as well as those administrators or executives with more than 1% of the share capital.
(*) Luis Sánchez-Lafuente Mariol indirectly has an additional 1.21% through the Bio Littletec Society, S.L.
01/07/2013 17:51 Relevant Fact: Significant Participations
Significant shareholdings.
| Shareholders |
% direct shareholding (*) |
| D. Miquel Àngel Bonachera Sierra |
14,02% |
| D. Sergi Audivert Brugué |
14,02% |
| D. Luis Sánchez-Lafuente Mariol |
9,83% |
Shareholders that held 10% of the share capital of ABBIOTICS S.A, as well as those administrators or executives with more than 1% of the share capital.
(*) Luis Sánchez-Lafuente Mariol indirectly has an additional 1.28% through the Bio Littletec Society, S.L.
11/03/2013 19:16 Relevant Fact: Significant Participations
Significant shareholdings.
| Shareholders |
% direct shareholding (*) |
| D. Miquel Àngel Bonachera Sierra |
14,02% |
| D. Sergi Audivert Brugué |
14,02% |
| D. Luis Sánchez-Lafuente Mariol |
9,83% |
Shareholders that held 10% of the share capital of ABBIOTICS S.A, as well as those administrators or executives with more than 1% of the share capital.
(*) Luis Sánchez-Lafuente Mariol indirectly has an additional 1.28% through the Bio Littletec Society, S.L.
09/01/2013 10:30 Relevant Fact: Significant Participations
Significant shareholdings.
| Shareholders |
% direct shareholding (*) |
| D. Miquel Àngel Bonachera Sierra |
17,67% |
| D. Sergi Audivert Brugué |
17,67% |
| D. Luis Sánchez-Lafuente Mariol |
12,29% |
Shareholders that held 10% of the share capital of ABBIOTICS S.A, as well as those administrators or executives with more than 1% of the share capital.
(*) Luis Sánchez-Lafuente Mariol indirectly has an additional 1.64% through the Bio Littletec Society, S.L.
Contact
